---
$id: https://graph.org.ai/products/commodity/51384618
$type: Product
source: UNSPSC
code: "51384618"
title: "Suxibuzone"
class: "51384600"
classTitle: "Nonsteroidal anti inflammatory pyrazoles"
family: "51380000"
familyTitle: "Nonsteroidal anti inflammatory drugs NSAIDs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Suxibuzone

**UNSPSC Code**: 51384618
**Class**: [Nonsteroidal anti inflammatory pyrazoles](Nonsteroidal anti inflammatory pyrazoles.mdx)
**Family**: [Nonsteroidal anti inflammatory drugs NSAIDs](../Nonsteroidal anti inflammatory drugs NSAIDs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C24H26N2O6, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 86TDZ5WP2B, chemically known as 3,5-pyrazolidinedione, 4-butyl-4-(hydroxymethyl)-1,2-diphenyl-, hydrogen succinate (ester) but generally known as suxibuzone, which bears US NIH Compound Identifier 5362. European Medicines Agency schedules Suxibuzone in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10789MIG. The term SUXIBUZONE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 25 , No. 10 1971, List 11). World Health Organization schedules suxibuzone in its Anatomical Therapeutic Chemical (ATC) Classification. SUXIBUZONE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule suxibuzone under HS 29331990 and SITC 51571. As of Q4 2014, SUXIBUZONE remains the US FDA Preferred Term for this commodity. Suxibuzone bears US NLM identifiers UMLS ID C0075667 and NCI Concept Code C73095. SMILES: O(CC1(CCCC)C(=O)N(N(C1=O)C1CCCCC1)C1CCCCC1)C(=O)CCC(=O)O.

